LISATA THERAPEUTICS, INC. Notes Payable
LISATA THERAPEUTICS, INC. (LSTA) had Notes Payable of $100.00 thousand as of 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:NotesPayable · last filed 2018-05-10
- 2018-03-31: Notes Payable $100.00K.
- 2017-12-31: Notes Payable $200.00K.
- 2017-09-30: Notes Payable $400.00K.
- 2017-06-30: Notes Payable $600.00K.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2018-03-31 | $100.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $200.00K 10-Q · filed 2018-05-10 | |
| 2017-09-30 | $400.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $600.00K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $1.20M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $700.00K 10-K · filed 2018-03-22 | $1.10M 10-K · filed 2017-03-17 |
| 2016-06-30 | $1.00M 10-Q · filed 2016-11-07 | $1.30M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.80M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.10M 10-Q · filed 2017-05-15 | $1.80M 10-K · filed 2016-03-15 |
| 2015-09-30 | $1.80M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $2.10M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.70M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $1.60M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $2.00M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $1.80M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.70M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $900.00K 10-K · filed 2015-03-02 | |
| 2013-09-30 | $800.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $500.00K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $300.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $400.00K 10-K · filed 2014-03-13 | $374.10K 10-K · filed 2013-03-11 |
| 2012-09-30 | $183.50K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $212.00K 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $148.10K 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |